chr10-72893847-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152635.3(OIT3):c.49G>A(p.Val17Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,609,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152635.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OIT3 | NM_152635.3 | c.49G>A | p.Val17Met | missense_variant | 1/9 | ENST00000334011.10 | |
OIT3 | NR_130125.2 | n.109G>A | non_coding_transcript_exon_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OIT3 | ENST00000334011.10 | c.49G>A | p.Val17Met | missense_variant | 1/9 | 1 | NM_152635.3 | P1 | |
OIT3 | ENST00000622652.1 | c.49G>A | p.Val17Met | missense_variant | 1/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000406 AC: 10AN: 246162Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 133140
GnomAD4 exome AF: 0.000194 AC: 282AN: 1457192Hom.: 0 Cov.: 30 AF XY: 0.000157 AC XY: 114AN XY: 724746
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152142Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.49G>A (p.V17M) alteration is located in exon 1 (coding exon 1) of the OIT3 gene. This alteration results from a G to A substitution at nucleotide position 49, causing the valine (V) at amino acid position 17 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at